Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
about
Biomarkers in heart failure with preserved ejection fractionNoninvasive Positive Pressure Ventilation in Chronic Heart FailurePredicting the occurrence of major adverse cardiac events within 30 days of a vascular surgery: an empirical comparison of the minimum p value method and ROC curve approach using individual patient data meta-analysis.Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskSurgical ventricular restoration to reverse left ventricular remodeling.Improved LFIAs for highly sensitive detection of BNP at point-of-carePlasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Systemic sclerosis and the heart: current diagnosis and management.NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort StudyN-terminal pro-brain natriuretic peptide and abnormal brain aging: The AGES-Reykjavik StudyClinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in TaiwanDiagnostic values of NT-proBNP in acute dyspnea among elderly patients.Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation.Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyEvaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy.2-Deoxy-d-Glucose (2-DG)-Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety BiomarkersBiomarkers in Acute Coronary Syndrome.Biological markers of oxidative stress: Applications to cardiovascular research and practice.N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of diseaseCardiotoxicity Following Cancer Treatment.Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.Narrative review: the management of acute decompensated heart failure.Updating the role of natriuretic peptide levels in cardiovascular disease.Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies.Clinical utility of natriuretic peptides in dialysis patients.The diagnostic utility of cardiac biomarkers in dialysis patients.Clinical utility of B-type natriuretic peptide (NP) in pediatric cardiac surgery--a systematic review.Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HFAmino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis.Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure.Natriuretic Peptide System Activation in Acute Heart Failure Patients with DiabetesThe prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome.Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.
P2860
Q26768192-CCD7BB4C-2A5B-4C00-A05A-001BE15DBA55Q28075185-420FF8FF-721D-4B19-A2C0-0B656AFE40E6Q31073733-E3DCEA33-E95B-496E-9156-CD36088D86CAQ33715302-420B658A-D628-4029-8E47-B9A95368CEB3Q33754169-F6EC2A4B-016A-4B05-BC0E-447BBE83411EQ33820936-7460A99D-EB0D-4773-AE0B-C41355EC1EABQ33848664-08D52FFC-1789-4622-A937-B594630F2073Q33862358-21D36E1B-C98B-4354-A521-5EBEABD0F427Q34012584-A897E76D-FAD0-4290-AB6D-8416971DC328Q34934407-7814F89B-2E91-4E71-BE3F-70ED0C406B36Q35089780-C717ED67-A767-485A-AFA8-A75429505DA1Q35801673-8E1EE4FD-254B-4A8B-AD69-D1E23F0CEDA2Q36005627-3D316583-C04B-4CC8-B093-89895A381E26Q36108948-FCDBBECD-0D8C-49FB-BA33-74155325D6BCQ36199888-7A5DF746-2821-451C-9CE5-BFB5A4C39587Q36262786-701C62AA-1843-4D4B-A6CD-C8CCB5489EE0Q36375532-39144BCE-2A3F-4F25-B913-A93261BAD720Q36423488-726E5F24-11E7-4A79-9D92-5A25E1E4BE8DQ36642014-005FA9BF-4E3A-45FF-A593-E20192D9EE01Q36836161-98E53E87-2A43-44D6-8464-F4A33F218A89Q36892819-F4FF7A39-7AE8-44CE-B27A-E225378A99A4Q37207294-3F24A703-BDD2-4543-838D-235530FFA063Q37313946-4D188B42-D950-4561-BFD7-7EA2C7CF1DEEQ37465179-914DE783-EEF8-489A-9F06-431C7C389CA1Q37553668-545820EF-A487-471C-AE72-037C04E85F80Q37663263-6DC9297B-4F91-4F9D-A241-638E784A3174Q37845737-2C8208E6-D058-4A7C-A1A1-69A7F409A03CQ37880500-FC90B36D-081D-41F1-935B-94525E2CBA23Q37959158-58492D60-2C12-444F-9FC6-F6C146BFE029Q37972865-F8BC14F6-01CB-4A1F-B9B5-C8570E942ABFQ38011232-236DC113-93E3-4101-97F4-7F0E7C34FADCQ38022786-F1996D3D-A2F0-4329-A971-E4432FA4D321Q38223232-FCF33C1B-3F0E-4EF0-A30A-15166DAE090DQ38424367-E38187AF-27BA-47E1-9897-FA20279CA7A0Q38854043-6FE89C87-51C8-4FBD-ACB3-97EE8A47A080Q39036840-36258D4A-4840-4CA3-8B78-D024C654E061Q40238774-2FCFC9A4-E01B-4896-AE45-BBDA13DA2177Q41448269-253B60C1-3D3A-44F4-A389-54BB6A777484Q42315010-99CB0FBA-F15C-44D1-8F99-33D5C58883C4Q42563345-E9ED12A2-0BD3-4D24-AFF4-8E0EF15BE1E1
P2860
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@ast
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@en
type
label
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@ast
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@en
prefLabel
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@ast
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@en
P2860
P356
P1433
P1476
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
@en
P2093
Michael Weber
P2860
P304
P356
10.1136/HRT.2005.071233
P407
P577
2006-06-01T00:00:00Z